stemmacolore
Cerca

Circulating markers as gender-specific predictors of response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients” – MAGNETIC Trial

Circulating markers as gender-specific predictors of response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients” – MAGNETIC Trial

Tipologia

Ricerca di base/clinica

Stato

aperto

Copertura

Nazionale

Ruolo dell'Istituto

Capofila

Ente finanziatore

IOV - IRCCS

Anno di finanziamento

2018

Principal Investigator

Dott.ssa Vanna Chiarion Sileni
Torna in alto